Understanding Long Noncoding RNA and Chromatin Interactions: What We Know So Far

被引:74
|
作者
Mishra, Kankadeb [1 ,2 ]
Kanduri, Chandrasekhar [1 ]
机构
[1] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, S-40530 Gothenburg, Sweden
[2] Mem Sloan Kettering Canc Ctr, Dept Cell Biol, Rockefeller Res Lab, 430 East 67th St,RRL 445, New York, NY 10065 USA
基金
瑞典研究理事会;
关键词
lncrna; chromatin; chromatin RNA; long noncoding RNA; gene regulation; RNA-chromatin interactions; REPEAT-CONTAINING RNA; R-LOOP FORMATION; ANTISENSE TRANSCRIPTION; WIDE IDENTIFICATION; ACTIVE CHROMATIN; BINDING PROTEIN; ENHANCER RNAS; CIRCULAR RNAS; X-CHROMOSOME; MAPS REVEAL;
D O I
10.3390/ncrna5040054
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
With the evolution of technologies that deal with global detection of RNAs to probing of lncRNA-chromatin interactions and lncRNA-chromatin structure regulation, we have been updated with a comprehensive repertoire of chromatin interacting lncRNAs, their genome-wide chromatin binding regions and mode of action. Evidence from these new technologies emphasize that chromatin targeting of lncRNAs is a prominent mechanism and that these chromatin targeted lncRNAs exert their functionality by fine tuning chromatin architecture resulting in an altered transcriptional readout. Currently, there are no unifying principles that define chromatin association of lncRNAs, however, evidence from a few chromatin-associated lncRNAs show presence of a short common sequence for chromatin targeting. In this article, we review how technological advancements contributed in characterizing chromatin associated lncRNAs, and discuss the potential mechanisms by which chromatin associated lncRNAs execute their functions.
引用
收藏
页数:28
相关论文
共 50 条
  • [1] What we know so far
    不详
    NEW SCIENTIST, 2021, 245 (3347) : 8 - 8
  • [2] What we know so far
    Gazzard, B
    AIDS, 1996, 10 : S3 - S7
  • [3] Vomocytosis: What we know so far
    Seoane, Paula I.
    May, Robin C.
    CELLULAR MICROBIOLOGY, 2020, 22 (02)
  • [4] Anabaenopeptins: What We Know So Far
    Monteiro, Patrick Romano
    do Amaral, Samuel Cavalcante
    Siqueira, Andrei Santos
    Xavier, Luciana Pereira
    Santos, Agenor Valadares
    TOXINS, 2021, 13 (08)
  • [5] Understanding the preterm human heart: What do we know so far?
    Schuermans, Art
    Lewandowski, Adam J.
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2022, 305 (09): : 2099 - 2112
  • [6] Amyloidogenesis: What Do We Know So Far?
    Alraawi, Zeina
    Banerjee, Nayan
    Mohanty, Srujana
    Kumar, Thallapuranam Krishnaswamy Suresh
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [7] ASPHALTENES: WHAT DO WE KNOW SO FAR
    Al-Qasim, Abdulaziz S.
    Alasker, Mohammed
    PROCEEDINGS OF THE ASME 36TH INTERNATIONAL CONFERENCE ON OCEAN, OFFSHORE AND ARCTIC ENGINEERING, 2017, VOL 8, 2017,
  • [8] Melanoma vaccines: What we know so far
    Bystryn, Jean-Claude
    Reynolds, Sandra R.
    ONCOLOGY-NEW YORK, 2005, 19 (01): : 97 - 108
  • [9] Incremental Hemodialysis: What We Know so Far
    Soi, Vivek
    Faber, Mark D.
    Paul, Ritika
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2022, 15 : 161 - 172
  • [10] Trichotillomania: What Do We Know So Far?
    Melo, Daniel Fernandes
    Lima, Caren dos Santos
    Piraccini, Bianca Maria
    Tosti, Antonella
    SKIN APPENDAGE DISORDERS, 2022, 8 (01) : 1 - 7